Singapore-founded digital therapeutics firm Biofourmis announced raising $300 million in a Series D funding round led by growth equity firm General Atlantic, taking its valuation past the $1 billion mark.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
